Hospital Quirón Sagrado Corazón

Seville 41013

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Estrogen Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer

Studies at this site

• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer — Running, not enrolling
• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early